secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADC Therapeutics SA (ADCT)
CIK:        0001771910
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0000950103-26-000349
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ADC Therapeutics posts updated corporate presentation with no material new disclosures
--------------------------------------------------------------------------------

- ADC Therapeutics made available an updated corporate presentation dated January 2026 via 8-K filing.
- The presentation excerpt contains only forward-looking statements boilerplate; no specific financial data or events.
- No changes to guidance, pipeline status, or leadership were disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1771910/000095010326000349/0000950103-26-000349-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1771910/000095010326000349/dp239825_8k.htm
  HTML page:      https://secwatch.observer/filing/0000950103-26-000349

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer